What’s driving Injective lower today?

What’s driving Injective lower today?
Injective slides 10.18% today

Injective (INJ) is currently trading at $4.01, a decline of 10.18% for the day, positioning it below the MA-20 at $4.89, MA-50 at $4.90, and well under the MA-200 at $9.44, highlighting sustained bearish pressure over multiple timeframes.

INJ price prediction
24H -0.95%
$5.23
48H -8.33%
$4.84
7D -9.09%
$4.8
1M 4.55%
$5.52
3M 149.43%
$13.17
6M 117.42%
$11.48
12M 96.4%
$10.37
Current price: $ 5.28 0.16 3.16%
Real-time Data 07:36
Daily range 5.09 Arrow from to Icon 5.3
Weekly range 4.89 Arrow from to Icon 5.84
Loading...

Highlights

  • INJ trades at $4.01, well below MA-20 ($4.89), MA-50 ($4.90), and MA-200 ($9.44), underpinning a firmly bearish setup across all timeframes.
  • Intraday momentum indicators (MACD, ADX, RSI 41.88, StochRSI 34.09, CCI –76.99) confirm persistent selling with price nearing, but not breaching, oversold territory.
  • Key price levels are $3.83 support and $5.05 resistance, with a projected five-day range of $3.83–$4.45 and less than 20% rebound probability.

Anton Kharitonov, expert at Traders Union, sees persistent technical weakness for INJ. He notes the price is trading below all key moving averages and momentum indicators reaffirm ongoing bearish control. Daily signals, including MACD, RSI, and CCI, all show sellers dominating without signs of reversal. The absence of supporting news flow only adds to the negative bias in sentiment. Kharitonov warns, "There is little to suggest the decline will pause, so traders should remain defensive and avoid catching falling knives at these levels."

Viktoras Karapetjanc, expert at Traders Union, focuses on forward-looking opportunities despite short-term pressure. He believes that volatility is setting the stage for range-bound plays within $3.83 to $4.45. The bullish structure could return rapidly if $5.05 is reclaimed. Although no recent news offers an immediate catalyst, Karapetjanc sees potential in upcoming sessions. He says, "Investors should watch support closely — further growth is expected if market sentiment pivots and resistance is broken."

Seller dominance confirmed as all momentum signals align bearish

Momentum remains weak, with the daily MACD showing a sell bias and ADX indicating a lack of a strong trend. The RSI (41.88), Stochastic RSI (34.09), and CCI (–76.99) point to a market edging toward oversold, though not yet deeply so. BBP and the Awesome Oscillator both favor the bears, confirming that sellers are dominating intraday moves. The price dropped 10.18% today after opening nearly flat to the previous session's close, with current levels near the lower end of the day’s trading range, reflecting high volatility and sustained selling pressure after the open. All key intraday and momentum signals align on a bearish tone, with no material divergence among oscillators and trend indicators.

Previously it was reported that Injective is trading under persistent bearish pressure, remaining well below its major moving averages with downside momentum prevailing across key technical indicators such as the MACD and ADX. Sellers maintain control as no clear support is identified and volatility remains high, suggesting the asset is likely to consolidate or trend lower within its current range barring a significant technical shift.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.